OBI Pharma, Inc. (TPEX:4174)

OBI Pharma Revenue

OBI Pharma had revenue of 5.56M TWD in the quarter ending March 31, 2026, a decrease of -61.52%. This brings the company's revenue in the last twelve months to 49.68M, down -26.94% year-over-year. In the year 2025, OBI Pharma had annual revenue of 58.58M, down -6.55%.

• Revenue (ttm): 49.68M
• Revenue Growth: -26.94%
• P/S Ratio: 75.75
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 3.76B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	58.58M	-4.10M	-6.55%
Dec 31, 2024	62.68M	21.13M	50.85%
Dec 31, 2023	41.55M	36.84M	781.96%
Dec 31, 2022	4.71M	-14.06M	-74.90%
Dec 31, 2021	18.77M	-122.11M	-86.68%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 26, 2026

Data Sources Report a data error